Paradoxical Response to Tuberculosis Treatment in a Patient Receiving Tumor Necrosis Factor-Alpha Antagonist Caroline Moureau, Lucie Pothen, MD, Dunja Wilmes, MD, Jean Cyr Yombi, MD, Emmanuel Coche, MD, PhD, Philippe Hainaut, MD, PhD The American Journal of Medicine Volume 125, Issue 6, Pages e9-e10 (June 2012) DOI: 10.1016/j.amjmed.2012.02.006 Copyright © 2012 Elsevier Inc. Terms and Conditions
Figure 1 Enhanced chest computed tomography at the beginning of treatment revealed small lymphadenopathy in the right retroclavicular and right paratracheal areas. The central portion of a lymph node in the right retroclavicular area showed low attenuation suggesting necrosis (arrow). The American Journal of Medicine 2012 125, e9-e10DOI: (10.1016/j.amjmed.2012.02.006) Copyright © 2012 Elsevier Inc. Terms and Conditions
Figure 2 Enhanced chest computed tomography after 2 months of treatment demonstrated a major increase in the size of lymphadenopathy with obvious necrosis (arrows) in both locations. The American Journal of Medicine 2012 125, e9-e10DOI: (10.1016/j.amjmed.2012.02.006) Copyright © 2012 Elsevier Inc. Terms and Conditions